Vertex Pharmaceuticals Incorporated is a company in the U.S. stock market and it is a holding in 150 U.S.-traded ETFs. VRTX has around 20.3M shares in the U.S. ETF market. The largest ETF holder of VRTX is the SPDR S&P 500 ETF Trust (SPY), with approximately 2.78M shares. Investors may also find of interest that the ETF with the largest allocation to VRTX stock is iShares NASDAQ Biotechnology ETF (IBB), with a portfolio weight of 6.81%. On average, U.S. ETFs allocate 0.69% of VRTX to their portfolios.
Additionally, VRTX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VRTX as a holding is the ProShares UltraPro QQQ (TQQQ), with a return of 51.26%.